SEC Form 4 · accession 0000905718-17-000829
Matinas BioPharma Holdings, Inc. · MTNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roelof Rongen
Officer — Chief Executive Officer · Director
Period of report
Sep 8, 2017
Accepted (ET)
Sep 11, 2017 · 9:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2017 | P | 5,000 | $1.36 | A | 3,539,416 | D |
Table II — derivative securities
No Table II lines on this filing.